首页> 外文期刊>Frontiers in Pharmacology >The AMP-Dependent Protein Kinase (AMPK) Activator A-769662 Causes Arterial Relaxation by Reducing Cytosolic Free Calcium Independently of an Increase in AMPK Phosphorylation
【24h】

The AMP-Dependent Protein Kinase (AMPK) Activator A-769662 Causes Arterial Relaxation by Reducing Cytosolic Free Calcium Independently of an Increase in AMPK Phosphorylation

机译:AMP依赖性蛋白激酶(AMPK)激活剂A-769662通过降低胞质游离钙而独立于AMPK磷酸化的增加而引起动脉松弛

获取原文
           

摘要

Although recent studies reveal that activation of the metabolic and Ca~(2+)sensor AMPK strongly inhibits smooth muscle contraction, there is a paucity of information about the potential linkage between pharmacological AMPK activation and vascular smooth muscle (VSM) contraction regulation. Our aim was to test the general hypothesis that the allosteric AMPK activator A-769662 causes VSM relaxation via inhibition of contractile protein activation, and to specifically determine which activation mechanism(s) is(are) affected. The ability of A-769662 to cause endothelium-independent relaxation of contractions induced by several contractile stimuli was examined in large and small musculocutaneous and visceral rabbit arteries. For comparison, the structurally dissimilar AMPK activators MET, SIM, and BBR were assessed. A-769662 displayed artery- and agonist-dependent differential inhibitory activities that depended on artery size and location. A-769662 did not increase AMPK-pT172 levels, but did increase phosphorylation of the downstream AMPK substrate, acetyl-CoA carboxylase (ACC). A-769662 did not inhibit basal phosphorylation levels of several contractile protein regulatory proteins, and did not alter the activation state of rhoA. A-769662 did not inhibit Ca~(2+)- and GTPγS-induced contractions in β-escin-permeabilized muscle, suggesting that A-769662 must act by inhibiting Ca~(2+)signaling. In intact artery, A-769662 immediately reduced basal intracellular free calcium ([Ca~(2+)]_(i)), inhibited a stimulus-induced increase in [Ca~(2+)]_(i), and inhibited a cyclopiazonic acid (CPA)-induced contraction. MET increased AMPK-pT172, and caused neither inhibition of contraction nor inhibition of [Ca~(2+)]_(i). Together, these data support the hypothesis that the differential inhibition of stimulus-induced arterial contractions by A-769662 was due to selective inhibition of a Ca~(2+)mobilization pathway, possibly involving CPA-dependent Ca~(2+)entry via an AMPK-independent pathway. That MET activated AMPK without causing arterial relaxation suggests that AMPK activation does not necessarily cause VSM relaxation.
机译:尽管最近的研究表明,代谢和Ca〜(2+)传感器AMPK的激活强烈抑制平滑肌收缩,但是关于药理AMPK激活与血管平滑肌(VSM)收缩调节之间潜在联系的信息很少。我们的目的是检验一般的假设,即变构AMPK激活剂A-769662通过抑制收缩性蛋白激活而引起VSM松弛,并具体确定哪些激活机制受到影响。在大大小小的肌肉皮肤和内脏家兔动脉中检查了A-769662引起由几种收缩刺激引起的内皮独立性收缩舒张的能力。为了进行比较,评估了结构不同的AMPK激活剂MET,SIM和BBR。 A-769662显示取决于动脉大小和位置的依赖于动脉和激动剂的差异抑制活性。 A-769662不会增加AMPK-pT172的水平,但会增加下游AMPK底物乙酰辅酶A羧化酶(ACC)的磷酸化。 A-769662不会抑制几种收缩蛋白调节蛋白的基础磷酸化水平,并且不会改变rhoA的激活状态。 A-769662不能抑制Ca-(2 +)-和GTPγS诱导的β-七叶皂素通透性肌肉的收缩,这表明A-769662必须通过抑制Ca〜(2+)信号传导来发挥作用。在完整的动脉中,A-769662立即降低基础细胞内游离钙([Ca〜(2 +)] _(i)),抑制刺激诱导的[Ca〜(2 +)] _(i)升高并抑制环吡嗪酸(CPA)引起的收缩。 MET增加了AMPK-pT172,并且既没有抑制收缩也没有抑制[Ca〜(2 +)] _(i)。总之,这些数据支持以下假设:A-769662对刺激诱导的动脉收缩的不同抑制是由于对Ca〜(2+)动员路径的选择性抑制,可能是通过CPA依赖的Ca〜(2+)进入。不依赖AMPK的途径。 MET激活AMPK而不引起动脉松弛表明AMPK激活不一定导致VSM松弛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号